Immunological Consequences of In Vitro Exposure to Lysergic Acid Diethylamide (LSD)
- 1 January 1994
- journal article
- research article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 16 (1) , 23-40
- https://doi.org/10.3109/08923979409029898
Abstract
The ability of lysergic acid diethylamide (LSD) to alter immune function after direct in vitro exposure was examined. It was demonstrated that LSD is able to suppress the proliferation of B-lymphocytes; the production of the cytokines IL-2, IL-4, and IL-6; and the induction of cytotoxic T-lymphocytes at a concentration of 100 μM. In vitro exposure to LSD had differential effects on natural killer (NK) cell activity, with significant enhancement of both basal and IL-2-augmented NK cell function at concentrations between 0.0001 and 0.1 μM, and suppression of NK response at 100 μM. These results demonstrate that LSD may have a direct effect on components of the immune system at concentrations that may be reached upon human exposure.Keywords
This publication has 18 references indexed in Scilit:
- Chromatographic and mass spectrometric methods for determination of lysergic acid diethylamide (LSD) and metabolites in body fluidsJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- Cell-mediated cytotoxicityCurrent Opinion in Immunology, 1992
- Diversity of Cytokine Synthesis and Function of Mouse CD4+ T CellsImmunological Reviews, 1991
- Critical care transportation medicine: New concepts in pretransport stabilization of the critically III patientThe American Journal of Emergency Medicine, 1990
- In vitro immunotoxicology and immunopharmacology: studies on drugs of abuseToxicology Letters, 1990
- The cytolytic T lymphocyte and its mode of actionImmunology Letters, 1989
- HallucinogensPediatric Clinics of North America, 1987
- Suppression of T-helper cell function in mice following exposure to the carcinogen 7,12-dimethylbenz[a]anthracene and its restoration by interleukin-2International Journal of Immunopharmacology, 1987
- Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.Proceedings of the National Academy of Sciences, 1986
- Regulation of cytotoxic lymphocyte precursorsCellular Immunology, 1986